Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Millendo Therapeutics (MLND)

Millendo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLND
DateTimeSourceHeadlineSymbolCompany
20/06/202320:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
20/06/202320:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
20/06/202320:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
16/06/202320:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
10/05/202320:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNDMillendo Therapeutics Inc
10/05/202320:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
01/05/202320:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MLNDMillendo Therapeutics Inc
01/05/202320:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MLNDMillendo Therapeutics Inc
28/04/202312:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
31/03/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
14/02/202319:57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNDMillendo Therapeutics Inc
14/02/202317:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MLNDMillendo Therapeutics Inc
29/12/202221:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
08/11/202214:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNDMillendo Therapeutics Inc
08/11/202213:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
04/10/202212:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
04/10/202212:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNDMillendo Therapeutics Inc
23/09/202220:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
15/08/202212:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNDMillendo Therapeutics Inc
15/08/202212:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202220:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
21/06/202212:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNDMillendo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLND